Launch a Paradigm Shift through an Innovative Diagnostic Test: Challenges and Opportunities through the lense of a Business Case Study
Joshua Krieger, PhD, Assistant Professor, Entrepreneurial Management Unit, Harvard Business School
Prof. Joshua Krieger from Harvard Business School shares his perspectives on some of the challenges and opportunities in commercialization of diagnostic tests and gives us a preview of his business case study on Genomic Health.
Challenges and Opportunities in Molecular Testing for Infectious Disease
Jennifer Dien Bard, PhD, D(ABMM), Director, Microbiology and Virology, Children’s Hospital Los Angeles; Associate Professor, Pathology and Laboratory Medicine, Keck School of Medicine, University of Southern California
Dr. Jennifer Dien Bard shares her insights into what the biggest challenges and opportunities are in implementing molecular point-of-care testing for infectious disease diagnostics, and rapid genetic and phenotypic susceptibility testing. Jennifer
will be speaking at Molecular Diagnostics for Infectious Disease and co-instructing a short course on Rapid Diagnostics for Antimicrobial Resistance at the Next Generation Dx Summit August 20 to 24, 2018 in Washington, DC.
Dissecting Liquid Biopsy in MBC: CTCs, ctDNA and CAMLs to Evaluate Innate Immunity
Massimo Cristofanilli, MD, FACP, Professor, Medicine; Associate Director, Translational Research and Precision Medicine; Director, OncoSET Precision Medicine Program, Medicine-Hematology and Oncology, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University
Prof. Massimo Cristofanilli shares his perspective on the future of liquid biopsy, the complementary purposes of CTC and cfDNA technologies, and when one should expect clinical utility of liquid biopsies.
Last Mile of Molecular Diagnostics in Precision Medicine and Healthcare
Bruce Quinn, MD, PhD, Principal, Bruce Quinn Associates
Dr. Bruce Quinn talks about his latest work, challenges to implementing precision medicine, advice for overcoming them and tips for integrating into the clinic. He discusses exciting new developments that are emerging and where the field is heading.
Rapid Fire: Getting to Know Suman Bose
Suman Bose, PhD, Postdoctoral Fellow, Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology
Suman Bose of Massachusetts Institute of Technology speaks to CHI on May 3, 2018. Dr. Bose will be speaking at the Single Cell Analysis and at the Microfluidics and Lab-on-a-Chip Devises for point of care testing tracks at the upcoming Next Generation
Diagnostics Summit that is held from August 20th through the 24th in Washington, D.C.
Looking at the Value of NGS-based Diagnostic Testing for Lung Cancer Patients
Daryl Pritchard, PhD, Professor, Bioengineering, University of Washington
Daryl Pritchard of PMC speaks to CHI on May 4th, 2018. Darryl will be speaking at a shared session between the Coverage and Reimbursement for Advanced Diagnostics Track and the Precision Medicine tracks at the upcoming Next-Generation Diagnostic
Summit that is held from August 20th to the 24th in Washington, D.C.
Developing Low Cost Diagnostics for Infectious Disease – Strategies and Advice
Paul Yager, PhD, Professor, Bioengineering, University of Washington
Paul Yager of University of Washington speaks to CHI on May 4, 2018. Dr. Paul Yager from the University of Washington. Dr. Yager will be speaking at the Enabling Point-of-Care Diagnostics and the Microfluidics and Lab-on-a-Chip Devices for point-of-care
testing tracks at the upcoming Next Generation Diagnostic Summit that is held from August 20th to the 24th in Washington, DC.
2017 Podcast Archive | 2016 Podcast Archive | 2015 Podcast Archive | 2014 Podcast Archive